Moreover, organoids derived from patients with CRC (PDOs) demonstrated higher ACTL6A levels than the matched normal colon organoids (Supplementary Fig. 2A), confirming that ACTL6A was markedly overexpressed in CRC tissues. This evidence concerns the gene ACTL6A and colorectal carcinoma.